Pulmonary fibrosis (PF) is a progressive, and life-threatening interstitial lung disease which
causes scarring in the lung parenchyma and thereby affects architecture and functioning of …

Amongst the various microtubule-targeting agents, Docetaxel (DTX) has gained immense
attention in cancer chemotherapy due to its good therapeutic index. DTX belongs to the …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death
worldwide. The destructive nature of the disease makes it difficult for clinicians to manage …

Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal condition that causes severe
scarring of the lungs. While the pathogenesis of IPF continues to be extensively studied and …

The application of nanotechnology to drug delivery systems for cancer therapy has
progressively received great attention. The most heavily investigated approach is the …

Afatinib (AFA) is a potent aniline–quinazoline derivative, approved by the Food and Drug
Administration (FDA) in 2013, as a first-line treatment for metastatic non-small cell lung …

Production and potential application of chitooligosaccharide is reported in this study.
Chitooligosaccharide was produced by enzymatic hydrolysis of chitosan using Bacillus …

Pulmonary drug delivery via aerosolization is a non-intrusive method for achieving localized
and systemic effects. The aim of this study was to establish the impact of viscosity as a novel …

Orally administered Sildenafil (SDF) is used to treat pulmonary arterial hypertension.
However, it has a relatively low bioavailability of approximately 40%. To circumvent such …

Ulcerative colitis (UC) with continuous and extensive inflammation is limited to the colon
mucosa and can lead to abdominal pain, diarrhea, and rectal bleeding. Conventional …